Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.39 |
| ▸ | NR1I3 | Q14994 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.39 |
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | VDR | P11473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17915188 | 0.99 | AURKA (0.40) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17915157 | 0.96 | MEN1 (0.41) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17915012 | 0.95 | MEN1 (0.42) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17915259 | 0.94 | ATM (0.47) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17914799 | 0.94 | CYP1A1 (0.46) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17914800 | 0.94 | CYP1A1 (0.46) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17914758 | 0.93 | HSD17B1 (0.42) | MEN1KMT2AADORA2AADORA1CYP1A2 | |
| SCHEMBL17915303 | 0.92 | CYP1A1 (0.45) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17915263 | 0.92 | CYP1A1 (0.45) | MEN1KMT2AATMAURKAAURKB | |
| SCHEMBL17915273 | 0.92 | ATM (0.46) | MEN1KMT2AATMAURKAAURKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10608189-B2 | Condensed cyclic compounds and organic light-emitting devices including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-03-31 | — | — | US | disclosed |
| US-20160204357-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | HEESUNG MATERIAL LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20160204357-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | HEESUNG MATERIAL LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20150349275-A1 | CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150349275-A1 | CONDENSED CYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10608189-B2 | Condensed cyclic compounds and organic light-emitting devices including the same | CRY1, CRY2, CCNE2 | MEN1 400/4885KMT2A 1753/4885ATM 1150/4885 |
| US-20160204357-A1 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | NOTUM, ORC3, PPOX | MEN1 1392/4885KMT2A 760/4885ATM 3125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.